Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Dong, Ning ^a   Xu, Bing ^a   Chu, Liqun ^a   Tang, Xin ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

ANGIOGENESIS; AQUEOUS HUMOR; ARTICLE; BLOOD RETINA BARRIER; CATARACT EXTRACTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIFFUSE MACULAR EDEMA; DISEASE DURATION; DISEASE SEVERITY; EYE INFLAMMATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOCAL MACULAR EDEMA; HUMAN; HYPERTENSION; IMMUNOASSAY; LOW LEVEL LASER THERAPY; MACULAR EDEMA; MACULAR THICKNESS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINA MACULA CYSTOID EDEMA; RETINAL THICKNESS; SLIT LAMP; VISUAL ACUITY; AGED; BIOSYNTHESIS; COMPLICATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; AQUEOUS HUMOR; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED;

EID: 84928805774     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125329     Document Type: Article

References (36)

1. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011; 34:1249-1257. doi: 10.2337/dc11-0442 PMID: 21617109
2. Ko F, Vitale S, Chou CF, Cotch MF, Saaddine J, Friedman DS. Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999-2002 and 2005-2008. JAMA. 2012; 308:2361-2368. doi: 10.1001/jama.2012.85685 PMID: 23232894
3. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Diabetic retinopathy. Diabetes Care. 2003; 26:226-229. PMID: 12502685
4. Wu L, Fernandez-Loaiza P, Sauma J, Hernandez-Bogantes E, Masis M. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes. 2013; 4:290-294. doi: 10.4239/wjd.v4.i6.290 PMID: 24379919
5. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984; 91:1-9. PMID: 6493722
6. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35:1-9.
7. Klein R, Klein B, Moss S, Cruickshanks K. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV. The longterm incidence. Ophthalmology. 1995; 102:7-16. PMID: 7831044
8. Dong N, Xu B, Wang B, Chu L. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis. 2013; 19:1734-1746. PMID: 23922491
9. Chu L, Wang B, Xu B, Dong N. Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery. Mol Vis. 2013; 19:2418-2425. PMID: 24319335
10. Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol. 2002; 133:70-77. PMID: 11755841
11. Jonas JB, Jonas RA, Neumaier M, Findeisen P. Cytokine concentration in aqueous humor of eyes with diabetic macular edema. Retina. 2012; 32:2150-2157. doi: 10.1097/IAE.0b013e3182576d07 PMID: 22617833
12. Funk M, Schmidinger G, Maar N, Bolz M, Benesch T, Zlabinger GJ, et al. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina. 2010; 30:1412-1419. doi: 10.1097/IAE.0b013e3181e095c0 PMID: 20711086
13. Sohn HJ, Han DH, Kim IT, Oh IK, Kim KH, Lee DY, et al. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol. 2011; 152:686-694. doi: 10.1016/j.ajo.2011.03.033 PMID: 21782151
14. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS report number 1. Arch Ophthalmology. 1985; 103:1796-1806. PMID: 2866759
15. Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PW. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg. 2011; 37:1589-1597. doi: 10.1016/j.jcrs.2011. 03.049 PMID: 21855759
16. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007; 114:881-889. PMID: 17275910
17. Bresnick GH. Diabetic macular edema. A review. Ophthalmology. 1986; 93:989-997. PMID: 3531959
18. Early Treatment Diabetic Retinopathy Study ResearchGroup. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991; 98:786-806. PMID: 2062513
19. Early Treatment Diabetic Retinopathy Study Research. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991; 98:823-833. PMID: 2062515
20. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, et al. Diabetic retinopathy. Diabetes Care. 1998; 21:143-156. PMID: 9538986
21. Chou TH, Wu PC, Kuo JZ, Lai CH, Kuo CN. Relationship of diabetic macular oedema with glycosylated haemoglobin. Eye (Lond). 2009; 23:1360-1363 doi: 10.1038/eye.2008.279 PMID: 18791547
22. Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW. Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand. 1999; 77:170-175 PMID: 10321533
23. Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci. 2008; 13:1227-1239. PMID: 17981625
24. Yao L, Sgadari C, Furuke K, Bloom ET, Teruya-Feldstein J, Tosato G. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood. 1999; 93:1612-1621. PMID: 10029590
25. Ribeiro FP, Furlaneto CJ, Hatanaka E, Ribeiro WB, Souza GM, Cassatella MA, et al. mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm. 2003; 12:173-178. PMID: 12857601
26. Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2010; 117:2146-2151. doi: 10.1016/j.ophtha.2010.08.016 PMID: 20855114
27. Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, doublemasked, multicenter phase II study. Diabetes Care. 2010; 33:2399-2405. doi: 10.2337/dc10-0493 PMID: 20980427
28. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994; 331:1480-1487. PMID: 7526212
29. Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 2007; 56:224-230. PMID: 17192486
30. Zhou J, Wang S, Xia X. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res. 2012; 37:416-420. doi: 10.3109/02713683.2012.661114 PMID: 22409294
31. Chernykh VV, Varvarinsky EV, Smirnov EV, Chernykh DV, Trunov AN. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy. Indian J Ophthalmol. 2015; 63:33-36. doi: 10.4103/0301-4738.151464 PMID: 25686060
32. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996; 271:736-741. PMID: 8557680
33. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992; 131:710-714. PMID: 1639018
34. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989; 170:2081-2095. PMID: 2531194
35. Xu AJ, Zhu W, Tian F, Yan LH, Li T. Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine. Mol Cell Biochem. 2010; 344:163-171. doi: 10. 1007/s11010-010-0539-x PMID: 20658311
36. Silvestre JS, Mallat Z, Duriez M, Tamarat R, Bureau MF, Scherman D, et aI. Antiangiogenic effect of interleukin- 10 in ischemia-induced angiogenesis in mice hindlimb. Circ Res. 2000; 87:448-452. PMID: 10988235